Assessment of Dissociative Traumatic Disorders
TEDI
1 other identifier
interventional
100
1 country
1
Brief Summary
More than 70% of ambulatory patients with IDD have attempted suicide (APA, 2015). This disorder, as well as all the disorders on the dissociation spectrum, must therefore be clarified and better diagnosed. The goal of this research is :
- 1.to assess the prevalence of dissociative disorders using specific tools in patients suffering from PTSD.
- 2.to validate the French version of the DDIS interview (Ross, 1997) that the investigators have translated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 5, 2019
CompletedFirst Submitted
Initial submission to the registry
April 29, 2020
CompletedFirst Posted
Study publicly available on registry
May 7, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 5, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 5, 2021
CompletedMay 7, 2020
May 1, 2020
1.6 years
April 29, 2020
May 6, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Post Traumatic Stress
assessment of the prevalence of dissociative disorders in a cohort of patients with PTSD
1 year
Study Arms (1)
Posttraumatic stress disorder
OTHERcohort of patients with Posttraumatic stress disorder PTSD
Interventions
Self assessment for the passing of the following rating scales CTQ-SF36-ITQ-PCL5-DES Hetero-assessment for the pasing of the following rating scales DDIS FR and medical interview
Eligibility Criteria
You may qualify if:
- Patient diagnosed with PTSD according to DSM 5 criteria
- Over 18 years of age
- Informed consent signed
You may not qualify if:
- Neurological disorders
- Serious and/or unstable somatic pathologies
- Patient not affiliated with social security
- Patient hospitalized under restraint in psychiatric care by decision of the state representative or in psychiatric care at the request of a third party
- Patient under guardianship
- Patient participating in parallel in another biomedical research
- Change of antidepressant in the last three months
- Patient not mastering the French language
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Januellead
Study Sites (1)
Youcef BENCHERIF
Neuilly-sur-Marne, Île-de-France Region, 93330, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Khalid KALALOU, Psychiatrist
EPS Ville Evrard
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Clinical research unit manager
Study Record Dates
First Submitted
April 29, 2020
First Posted
May 7, 2020
Study Start
February 5, 2019
Primary Completion
September 5, 2020
Study Completion
September 5, 2021
Last Updated
May 7, 2020
Record last verified: 2020-05